Oxycodone attenuates vascular leak and lung inflammation in a clinically relevant two-hit rat model of acute lung

Xinyi Li1, Rui Li2, Qing Fang1

  • 1Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Cytokine
|November 14, 2020
PubMed
Abstract

Insights

Oxycodone pretreatment protects against acute lung injury (ALI) by modulating tight junctions and aquaporins. These effects are mediated through kappa- and mu-opioid receptors, reducing inflammation and apoptosis.

Area of Science:

  • Pharmacology
  • Pulmonary Medicine
  • Cell Biology

Background:

  • Acute lung injury (ALI) is a critical condition with significant morbidity and mortality.
  • Opioid receptor agonists, like oxycodone, have shown potential in mitigating lung injury.
  • The specific mechanisms involving tight junctions and aquaporins in oxycodone's protective effects against ALI require further elucidation.

Purpose of the Study:

  • To investigate the protective effects of oxycodone pretreatment on lipopolysaccharide (LPS) and mechanical ventilation (MV)-induced ALI.
  • To determine if oxycodone modulates alveolar tight junctions (TJs) and aquaporins (AQPs) in the context of ALI.
  • To explore the involvement of kappa (KOR), mu (MOR), and delta (DOR) opioid receptors in oxycodone's protective actions.

Main Methods:

  • A two-hit model of ALI was established in Sprague Dawley rats and A59 cells using LPS and MV.
  • Animals and cells were pretreated with oxycodone, with or without specific opioid receptor antagonists (KOR, MOR, DOR).
  • Histological lung changes, pulmonary microvascular permeability, TJ and AQP expression, inflammatory markers, and apoptosis were assessed.

Main Results:

  • Oxycodone pretreatment alleviated lung injury, reduced microvascular permeability, and suppressed inflammation and apoptosis in ALI models.
  • Oxycodone upregulated tight junction proteins (claudin-5, ZO-1) and aquaporins (AQP1, AQP5).
  • The protective effects were diminished by KOR and MOR antagonists, but not by DOR antagonists, suggesting KOR and MOR mediation.

Conclusions:

  • Oxycodone pretreatment ameliorates LPS- and MV-induced lung injury.
  • The protective mechanisms involve the modulation of tight junctions, aquaporins, inflammation, and apoptosis via KOR and MOR.
  • Oxycodone may exert its effects by inhibiting the TLR4/NF-κB signaling pathways.